News
Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart ...
14h
MedPage Today on MSNFinerenone Gets Expanded FDA Approval in Heart FailureThe FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.
Heart failure, a condition where the heart doesn't pump blood efficiently, manifests through symptoms like shortness of ...
Scientists have discovered that four health habits — which include sleep quality and nicotine use — were the most important ...
Micah Clayborne was diagnosed with Danon disease, a rare condition, after complaining of chest pains. He needed a heart ...
Heart failure, a leading cause of death in the US, can be triggered by cardiac amyloidosis, a condition often misdiagnosed as ...
Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...
The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...
11hon MSN
You know our consumer advisor, Clark Howard, as someone who saves you time and money. But did you know he had a near-death ...
The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.
A new system involving heart failure nurses at a Norfolk hospital has seen device alert response times plummet from weeks to ...
Discover how MemorialCare's Women's Heart Center at Long Beach is tackling the leading killer of women, heart disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results